Invention Grant
- Patent Title: Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
-
Application No.: US14859139Application Date: 2015-09-18
-
Publication No.: US09890164B2Publication Date: 2018-02-13
- Inventor: Naoki Tsuno , Jiangchao Yao
- Applicant: Purdue Pharma, L.P. , Shionogi & Co., Ltd.
- Applicant Address: US CT Stamford JP Osaka-Shi
- Assignee: Purdue Pharma, L.P.,Shionogi & Co., LTD.
- Current Assignee: Purdue Pharma, L.P.,Shionogi & Co., LTD.
- Current Assignee Address: US CT Stamford JP Osaka-Shi
- Agency: Dechert LLP
- Main IPC: C07D241/44
- IPC: C07D241/44 ; C07D471/08 ; C07D403/04 ; C07D451/14

Abstract:
Compounds of Formula (I): where R1, R2, R5, a, and b are disclosed herein, and pharmaceutically acceptable derivatives thereof (a “Substituted-Quinoxaline-Type Bridged-Piperidine Compound”), compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
Public/Granted literature
- US20160009717A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF Public/Granted day:2016-01-14
Information query